The history of targeted therapy
Authors: I.A. Gerk
This article will consider in detail the prerequisites for the emergence and development of targeted therapy in general, as well as various groups of drugs in particular. From the appearance of the first monoclonal antibodies and tyrosine kinase inhibitors to the emergence of conjugated antibodies. Data on the effectiveness of modern targeted drugs will also be presented and an assessment of their potential contribution to the treatment of oncological diseases will be given.